Yoko Tachibana
University of North Carolina at Chapel Hill
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Yoko Tachibana.
Bioorganic & Medicinal Chemistry | 2002
Junko Ishida; Hironori Ohtsu; Yoko Tachibana; Yuka Nakanishi; Kenneth F. Bastow; Masahiro Nagai; Hui Kang Wang; Hideji Itokawa; Kuo Hsiung Lee
Fifty-eight curcumin analogues were prepared and evaluated for in vitro cytotoxicity against a panel of human tumor cell lines. Compound was the most potent analogue against several cell lines, including HOS (bone cancer) and 1A9 (breast cancer), with ED50 values of 0.97 and <0.63 microg/mL, respectively.
Bioorganic & Medicinal Chemistry | 2001
Kinuko Iwasa; Masataka Moriyasu; Yoko Tachibana; Hye-Sook Kim; Yusuke Wataya; Wolfgang Wiegrebe; Kenneth F. Bastow; L. Mark Cosentino; Mutsuo Kozuka; Kuo Hsiung Lee
Twenty-six simple isoquinolines and 21 benzylisoquinolines were tested for antimicrobial, antimalarial, cytotoxic, and anti-HIV activities. Some simple isoquinoline alkaloids were significantly active in each assay, and may be useful as lead compounds for developing potential chemotherapeutic agents. These compounds include 13 (antimicrobial), 25, 26, and 42 (antimalarial), 13 and 25 (cytotoxic), and 28 and 29 (anti-HIV). A quaternary nitrogen atom of isoquinolium or dihydroisoquinolinium type may contribute to enhanced potency in the first three types of activities. In contrast, anti-HIV activity was found with tetrahydroisoquinoline and 6,7-dihydroxyisoquinolium salts.
Phytomedicine | 2001
Hidenori Ueda; Yoko Tachibana; Masataka Moriyasu; Kazuko Kawanishi; Sérgio de Mello Alves
Aldose reductase inhibitors were isolated from an extract of the dry fruits of Caesalpinia ferrea Mart. (Leguminosae). Compound 2 was identified as ellagic acid by comparison with a reference sample. The structure of compound 1 was elucidated as 2-(2,3,6-trihydroxy-4-carboxyphenyl) ellagic acid on the basis of spectral evidence, especially 2D-NMR data (HMQC, HMBC and NOESY). These two compounds inhibited aldose reductase in a non-competitive manner.
Phytochemistry | 1996
Yumi Nishiyama; Masataka Moriyasu; Momoyo Ichimaru; Yoko Tachibana; Atsushi Kato; Simon G. Mathenge; Joseph N. Nganga; Francis D. Juma
Abstract From the dried bark of Ekebergia capensis, two novel acyclic triterpenoids, 2,3,22,23-tetrahydroxy-2,6,10,15,19,23-hexamethyl-6,10,14,18-tetracosatetraene and 2-hydroxymethyl-2,3,22,23-tetrahydroxy-6,10,15,19,23-pentamethyl-6,10,14,18-tetracosatetraene were isolated, along with known cyclic triterpenoids. The structures of these two new triterpenoids were determined by spectroscopic and chemical methods.
Bioorganic & Medicinal Chemistry Letters | 1999
Zheng Yu Yang; Yi Xia; Peng Xia; Yoko Tachibana; Kenneth F. Bastow; Kuo Hsiung Lee
Several substituted 8,8-dimethyl-2H,8H-pyrano[6,5-h]quinoline-2-ones and related compounds were synthesized and evaluated for their in vitro cytotoxicity against a panel of human tumor cell lines. The most active compound (3) showed significant cytotoxic activity with GI50 values in the micromolar range.
Cancer Letters | 2000
Masao Fukushima; Narihiko Fukamiya; Masayoshi Okano; Tatsuo Nehira; Kiyoshi Tagahara; Shun Xiang Zhang; De Cheng Zhang; Yoko Tachibana; Kenneth F. Bastow; Kuo Hsiung Lee
Seven taxane diterpenes were isolated from the EtOH extract of the aerial parts of Taxus chinensis, and evaluated for cytotoxicity against nine human cell lines, including a beta-tublin mutant resistant to paclitaxel. Compound 2, a non-alkaloid-type taxane diterpene, showed significant cytotoxicity in most cell lines, and notably, equipotent against both parental and beta-tublin mutant tumor cell lines.
Bioorganic & Medicinal Chemistry | 1998
Jian Guan; Xiao Kang Zhu; Yoko Tachibana; Kenneth F. Bastow; Arnold Brossi; Ernest Hamel; Kuo Hsiung Lee
Demethylation of colchiceinamide (2) and its analogues (3-10) afforded a novel class of mammalian DNA topoisomerase II inhibitors (2a-10a) without displaying tubulin inhibitory activity. All target compounds inhibited the catalytic activity of topoisomerase II at drug concentrations at 100 microM. An in vitro cytotoxicity assay indicated that compounds 3a and 8a were strong and tissue-selective cytotoxic agents against the MCF-7 breast cancer cell line (IC50 = 0.36 and 0.48 microgram/mL, respectively) and the CAKI-1 renal cancer cell line (IC50 = 0.72 and 0.96 microgram/mL, respectively).
The Chinese Pharmaceutical Journal | 2003
Masayoshi Oyama; Kenneth F. Bastow; Yoko Tachibana; Yoshiaki Shirataki; Sadaki Yamaguchi; Gordon M. Cragg; Tian Shung Wu; Kuo Hsiung Lee
Two novel prenylated acetophenone dimers, acrofoliones A (1) and B (2), were isolated from Acronychia trifoliolata (Rutaceae) to gether with a known cytotoxic principle, acrovestone (3). The new structures were determined from NMR and MS spectroscopic anal y sis. Com pounds 1 and 2 showed only moderate cytotoxicity against HCT-8 and KB cells with ED50 values of 4.3 and 4.8 μg/mL, respectively; how ever, both compounds demonstrated selectivity against MOLT-4 and RPMI-8225 leukemia cell lines.
Anti-Cancer Drugs | 2000
Yoko Tachibana; Xiao-Kang Zhu; Preethi Krishnan; Kuo Hsiung Lee; Kenneth F. Bastow
A new semi-synthetic podophyllotoxin derivative, 4′-O-demethyl-4β-(2′′-nitro-4′′-fluoroanilino)-4-desoxypodophyllotoxin (compound 1), an analog of GL-331 (compound 2), is a potent and broad-spectrum inhibitor of cultured human cancer and drug-resistant cell growth. In general, 4′-demethylepipodophyllotoxin analogs, including 2, exert anti-tumor activity by targeting the nuclear enzyme DNA topoisomerase II, but 1 is not an enzyme inhibitor. Unlike the cytotoxic activity of compound 2, cell killing by 1 is dose-limiting and a significant fraction of cells (30-40%) survive treatment. As an approach to investigate mechanism of action, 1-resistant A549 (human lung cancer) sub-lines were selected and characterized. Results of the work show that 1-resistant cells: (i) are moderately cross-resistant (2- to 3-fold) to various cytotoxic drugs via a P-glycoprotein-independent mechanism, (ii) have an altered growth habit, (iii) are deficient in normal attachment on plastic and collagen substrata, and (iv) have an altered plasma membrane protein composition including several proteins in the 140->200 kDa molecular mass range and a doublet of phosphoserine-containing proteins of about 135 kDa. Since 1 treatment of cells affects neither cellular attachment or membrane-protein phosphorylation, the changes observed in 1-resistant cells are interpreted as a survival response to drug action.
Phytomedicine | 1996
Yoko Tachibana; Atsushi Kato; Yumi Nishiyama; M. Ikemi; K. Ohoka; Kazuko Kawanishi; Francis D. Juma; Joseph N. Nganga; Simon G. Mathenge
Mitogenic activities in African traditional herbal medicines were examined on human peripheral blood lymphocytes and mouse spleen cells using protein fractions obtained from their extracts by precipitation with ammonium sulfate. Target specificity for these mitogens was investigated by using isolated T cells and lymphocytes from athymic nude mice. Among 20 plants investigated, potent mitogenic activities for both human and mouse lymphocytes were found in 7 plants: Monanthotaxis sp. (Annonaceae), Uvaria lucida (Annonaceae), Maytenus buchananii (Celastraceae), Lonchocarpus bussei (Leguminosae), Phytolacca dodecandra (Phytolaccaceae), Phytolacca octandra (Phytolaccaceae), and Toddalia asiatica (Rutaceae). The U. lucida stem demonstrated the highest activity among all and induced mitogenesis both in human and mouse isolated T cells, but not in lymphocytes from athymic nude mice.